Volume 22, Number 5—May 2016
Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014
|Category||No. (%) cases||Patient median age, y||No. % male patients|
|All KFGH-acquired cases
|Cohort study case-patient†||50 (64.1)||56||37 (74.0)|
|Healthcare worker at KFGH||16 (20.5)||47||12 (75.0)|
|Visited patient treated at KFGH||9 (11.5)||47||8 (88.9)|
|Outpatient appointment at KFGH||3 (3.8)||59||2 (66.7)|
*Cases were categorized as potentially KFGH-acquired for persons who had KFGH contact before MERS onset. KFGH, King Fahd General Hospital; MERS, Middle East respiratory syndrome.
†Patients with MERS onset 2‒14 days after emergency department, inpatient, or dialysis treatment at KFGH. Includes 3 healthcare workers (1 who worked at KFGH and 2 at other hospitals) who were admitted to KFGH inpatient areas or emergency department 2‒14 days before MERS onset.
1These authors contributed equally to this article.
2Current affiliation: International Medical Center, Jeddah, Saudi Arabia.
3Current affiliation: Pfizer Inc., Collegeville, Pennsylvania, USA.